Bio-Techne Ownership | Who Owns Bio-Techne?


OverviewForecastRevenueFinancialsChartTranscripts

Bio-Techne Ownership Summary


Bio-Techne is owned by 99.15% institutional investors, 1.04% insiders. Vanguard group is the largest institutional shareholder, holding 11.56% of TECH shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 3.68% of its assets in Bio-Techne shares.

TECH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBio-Techne99.15%1.04%-0.19%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group18.18M11.56%$1.30B
Blackrock14.99M9.53%$1.07B
Price t rowe associates inc /md/8.53M5.42%$610.87M
State street6.30M4.01%$451.46M
Bamco inc /ny/4.78M3.04%$342.24M
Morgan stanley4.41M2.80%$316.03M
Ameriprise financial4.10M2.61%$293.94M
Geode capital management3.91M2.48%$279.19M
Neuberger berman group3.54M2.25%$253.35M
Df dent3.37M2.15%$241.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Broadcrest asset management100.00K9.37%$7.62M
Montanaro asset management304.80K4.07%$21.84M
Brown capital management2.43M3.52%$174.08M
Jackson square partners763.79K3.34%$54.73M
Sandhill capital partners569.88K3.13%$40.83M
Df dent3.37M3.13%$241.77M
Pembroke management317.76K3.06%$22.77M
Eversept partners, lp543.04K2.66%$38.91M
American capital management1.09M2.61%$77.88M
Summit creek advisors250.49K2.46%$17.95M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/8.53M0.07%2.78M
Norges bank1.90M0.02%1.90M
Ameriprise financial4.10M0.08%821.35K
Fmr1.42M0.01%314.27K
Sumitomo mitsui trust1.71M0.09%290.51K

Top Sellers

HolderShares% AssetsChange
Blackrock14.99M0.02%-2.76M
William blair investment management1.13M0.21%-1.04M
Alyeska investment group---911.53K
Eagle asset management308.84K0.12%-702.23K
American century companies839.11K0.04%-570.82K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.90M0.02%1.90M$136.43M
Mirae asset global etfs109.37K0.02%109.37K$7.84M
Worldquant millennium advisors100.75K0.07%100.75K$7.22M
Weitz investment management44.10K0.17%44.10K$3.16M
Corebridge financial40.25K0.02%40.25K$2.88M

Sold Out

HolderChange
Tfo-tdc-1.00
Scarborough advisors-2.00
Colonial trust advisors-3.00
Riggs asset managment-4.00
Capital advisors-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20245681.25%155,969,245-0.67%991.00%2761.47%20611.96%
Mar 31, 20245614.28%157,019,3151.00%991.02%272-7.48%18411.52%
Dec 31, 20235380.75%155,459,8623.52%981.09%29427.27%165-22.90%
Sep 30, 2023534-0.19%150,166,833-0.61%941.03%231-8.70%21413.83%
Jun 30, 2023535-3.78%151,081,8701.56%951.07%253-10.60%1881.62%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
US Small-Cap Growth II Equity Comp5.83M3.68%894.41K
T. Rowe Price New Horizons5.83M3.68%113.43K
Vanguard Total Stock Mkt Idx Inv5.03M3.17%-19.75K
Vanguard Institutional 500 Index Trust4.18M2.63%48.53K
Vanguard Small Cap Index3.98M2.50%7.80K
Champlain Mid Cap Fund, LLC2.49M1.57%-83.06K
Eaton Vance Atlanta Capital SMID-Cap I2.48M1.56%294.68K
Baron Small Cap Growth Strategy2.33M1.47%-165.00K
Baron Growth Retail2.33M1.47%-165.00K
Neuberger Berman Genesis Inv2.20M1.39%-10.42K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2024BAUMGARTNER ROBERT V-Sell$1.15M
May 14, 2024HIGGINS JOHN L-Sell$335.38K
Mar 07, 2024Nusse Roeland-Sell$800.63K
Aug 30, 2023Nusse Roeland-Sell$717.96K
Jul 21, 2023Kummeth Charles R. Chief Executive OfficerSell$7.07M

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2-1
2024 Q1-1
2023 Q4--
2023 Q3-2

TECH Ownership FAQ


Who Owns Bio-Techne?

Bio-Techne shareholders are primarily institutional investors at 99.15%, followed by 1.04% insiders and -0.19% retail investors. The average institutional ownership in Bio-Techne's industry, Biotech Stocks , is 44.97%, which Bio-Techne exceeds.

Who owns the most shares of Bio-Techne?

Bio-Techne’s largest shareholders are Vanguard group (18.18M shares, 11.56%), Blackrock (14.99M shares, 9.53%), and Price t rowe associates inc /md/ (8.53M shares, 5.42%). Together, they hold 26.51% of Bio-Techne’s total shares outstanding.

Does Blackrock own Bio-Techne?

Yes, BlackRock owns 9.53% of Bio-Techne, totaling 14.99M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 1.07B$. In the last quarter, BlackRock decreased its holdings by -2.758M shares, a -15.54% change.

Who is Bio-Techne’s biggest shareholder by percentage of total assets invested?

Broadcrest asset management is Bio-Techne’s biggest shareholder by percentage of total assets invested, with 9.37% of its assets in 100K Bio-Techne shares, valued at 7.62M$.

Who is the top mutual fund holder of Bio-Techne shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Bio-Techne shares, with 3.68% of its total shares outstanding invested in 5.83M Bio-Techne shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools